FindTrial
Sign In

A systematic review of the efficacy of macrolides for bronchial asthma in adults

A systematic review of the efficacy of macrolides for bronchial asthma in adults - Macrolides for bronchial asthma in adults

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000050533
Enrollment
Unknown
Registered
2023-03-08
Start date
2023-03-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchial asthma

Interventions

None listed

Sponsors

Japanese Society of Allergology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with bronchial asthma

Exclusion criteria

Exclusion criteria: Not determined

Design outcomes

Primary

MeasureTime frame
Exacerbation requiring hospitalization—

Secondary

MeasureTime frame
Severe exacerbation Symptom score ACQ AQLQ SABA FEV1 PEF Serious adverse events including death All adverse events Airway hyperreactivity Inflammation (peripheral blood eosinophils/sputum eosinophils) OCS serum/sputum ECP FENO—

Countries

Japan

Contacts

Public ContactNagano Tatsuya

Kobe University Hospital Respiratory Medicine

tnagano@med.kobe-u.ac.jp0783825660

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026